LncRNA SNHG6 promotes glycolysis reprogramming in hepatocellular carcinoma by stabilizing the BOP1 protein

References

• Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, Bartrons R, Gottlieb E, Vousden KH. 2006. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell. 126:107–120.
   PubMed Web of Science ®Google Scholar
• Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi B, Varambally S. 2017. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 19:649–658.
   PubMed Web of Science ®Google Scholar
• Chang L, Yuan Y, Li C, Guo T, Qi H, Xiao Y, Dong X, Liu Z, Liu Q. 2016. Upregulation of SNHG6 regulates ZEB1 expression by competitively binding miR-101-3p and interacting with UPF1 in hepatocellular carcinoma. Cancer Lett. 383:183–194.
   PubMed Web of Science ®Google Scholar
• Chen B, Dragomir MP, Fabris L, Bayraktar R, Knutsen E, Liu X, Tang C, Li Y, Shimura T, Ivkovic TC, et al. 2020. The long noncoding RNA CCAT2 induces chromosomal instability through BOP1-AURKB signaling. Gastroenterology. 159:2146–2162.e2133.
   PubMed Web of Science ®Google Scholar
• Chen K, Hou Y, Liao R, Li Y, Yang H, Gong J. 2021. LncRNA SNHG6 promotes G1/S-phase transition in hepatocellular carcinoma by impairing miR-204-5p-mediated inhibition of E2F1. Oncogene. 40:3217–3230.
   PubMed Web of Science ®Google Scholar
• Chung KY, Cheng IK, Ching AK, Chu JH, Lai PB, Wong N. 2011. Block of proliferation 1 (BOP1) plays an oncogenic role in hepatocellular carcinoma by promoting epithelial-to-mesenchymal transition. Hepatology. 54:307–318.
   PubMed Web of Science ®Google Scholar
• Corcoran SE, O'Neill LA. 2016. HIF1alpha and metabolic reprogramming in inflammation. J Clin Invest. 126:3699–3707.
   PubMed Web of Science ®Google Scholar
• Dando I, Cordani M, Donadelli M. 2016. Mutant p53 and mTOR/PKM2 regulation in cancer cells. IUBMB Life. 68:722–726.
   PubMed Web of Science ®Google Scholar
• Du F, Guo T, Cao C. 2020. Silencing of long noncoding RNA SNHG6 inhibits esophageal squamous cell carcinoma progression via miR-186-5p/HIF1alpha axis. Dig Dis Scit. 65:2844–2852.
   PubMed Web of Science ®Google Scholar
• Fan X, Zhao Z, Song J, Zhang D, Wu F, Tu J, Xu M, Ji J. 2021. LncRNA-SNHG6 promotes the progression of hepatocellular carcinoma by targeting miR-6509-5p and HIF1A. Cancer Cell Int. 21:150.
   PubMed Web of Science ®Google Scholar
• Feng J, Li J, Wu L, Yu Q, Ji J, Wu J, Dai W, Guo C. 2020. Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma. J Exp Clin Cancer Res. 39:126.
   PubMed Web of Science ®Google Scholar
• Goodall GJ, Wickramasinghe VO. 2021. RNA in cancer. Nat Rev Cancer. 21:22–36.
   PubMed Web of Science ®Google Scholar
• Guo W, Qiu Z, Wang Z, Wang Q, Tan N, Chen T, Chen Z, Huang S, Gu J, Li J, et al. 2015. MiR-199a-5p is negatively associated with malignancies and regulates glycolysis and lactate production by targeting hexokinase 2 in liver cancer. Hepatology. 62:1132–1144.
   PubMed Web of Science ®Google Scholar
• Gupta R, Bugide S, Wang B, Green MR, Johnson DB, Wajapeyee N. 2019. Loss of BOP1 confers resistance to BRAF kinase inhibitors in melanoma by activating MAP kinase pathway. Proc Natl Acad Sci U S A. 116:4583–4591.
   PubMed Web of Science ®Google Scholar
• He J, Chen Z, Xue Q, Shi W. 2022. Block of proliferation 1 promotes proliferation, invasion and epithelial mesenchymal transformation in gastric cancer. Oxid Med Cell Longev. 2022:2946989.
   PubMed Web of Science ®Google Scholar
• Heiden MG V, Cantley LC, Thompson CB. 2009. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 324:1029–1033.
   PubMed Web of Science ®Google Scholar
• Hernandez-Gea V, Toffanin S, Friedman SL, Llovet JM. 2013. Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma. Gastroenterology. 144:512–527.
   PubMed Web of Science ®Google Scholar
• Jafari-Oliayi A, Asadi MH. 2019. SNHG6 is upregulated in primary breast cancers and promotes cell cycle progression in breast cancer-derived cell lines. Cell Oncol (Dordr). 42:211–221.
   PubMed Web of Science ®Google Scholar
• Jones RG, Thompson CB. 2009. Tumor suppressors and cell metabolism: a recipe for cancer growth. Genes Dev. 23:537–548.
   PubMed Web of Science ®Google Scholar
• Lan Z, Yao X, Sun K, Li A, Liu S, Wang X. 2020. The interaction between lncRNA SNHG6 and hnRNPA1 contributes to the growth of colorectal cancer by enhancing aerobic glycolysis through the regulation of alternative splicing of PKM. Front Oncol. 10:363.
   PubMed Web of Science ®Google Scholar
• Levine AJ, Puzio-Kuter AM. 2010. The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science. 330:1340–1344.
   PubMed Web of Science ®Google Scholar
• Li S, Wu H, Huang X, Jian Y, Kong L, Xu H, Ouyang Y, Chen X, Wu G, Yu L, et al. 2021. BOP1 confers chemoresistance of triple-negative breast cancer by promoting CBP-mediated beta-catenin acetylation. J Pathol. 254:265–278.
   PubMed Web of Science ®Google Scholar
• Liu J, Zhang C, Hu W, Feng Z. 2015. Tumor suppressor p53 and its mutants in cancer metabolism. Cancer Lett. 356:197–203.
   PubMed Web of Science ®Google Scholar
• Lu C, Rong D, Zhang B, Zheng W, Wang X, Chen Z, Tang W. 2019. Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities. Mol Cancer. 18:130.
   PubMed Web of Science ®Google Scholar
• Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, Gavrilova O, Hurley PJ, Bunz F, Hwang PM. 2006. P53 regulates mitochondrial respiration. Science. 312:1650–1653.
   PubMed Web of Science ®Google Scholar
• Pu FF, Shi DY, Chen T, Liu YX, Zhong BL, Zhang ZC, Liu WJ, Wu Q, Wang BC, Shao ZW, et al. 2021. SP1-induced long non-coding RNA SNHG6 facilitates the carcinogenesis of chondrosarcoma through inhibiting KLF6 by recruiting EZH2. Cell Death Dis. 12:59.
   PubMed Web of Science ®Google Scholar
• Rinn JL, Chang HY. 2020. Long noncoding RNAs: molecular modalities to organismal functions. Annu Rev Biochem. 89:283–308.
   PubMed Web of Science ®Google Scholar
• Schwartzenberg-Bar-Yoseph F, Armoni M, Karnieli E. 2004. The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res. 64:2627–2633.
   PubMed Web of Science ®Google Scholar
• Semenza GL. 2013. HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations. J Clin Invest. 123:3664–3671.
   PubMed Web of Science ®Google Scholar
• Strezoska Z, Pestov DG, Lau LF. 2000. Bop1 is a mouse WD40 repeat nucleolar protein involved in 28S and 5. 8S RRNA processing and 60S ribosome biogenesis. Mol Cell Biol. 20:5516–5528.
   PubMed Web of Science ®Google Scholar
• Teoh ST, Lunt SY. 2018. Metabolism in cancer metastasis: bioenergetics, biosynthesis, and beyond. Wiley Interdiscip Rev Syst Biol Med. 10:e1406. doi:10.1002/wsbm.1406
   PubMed Web of Science ®Google Scholar
• The L. 2018. GLOBOCAN 2018: counting the toll of cancer. Lancet. 392:985.
   PubMed Web of Science ®Google Scholar
• Wang H, Ma P, Liu P, Guo D, Liu Z, Zhang Z. 2021. lncRNA SNHG6 promotes hepatocellular carcinoma progression by interacting with HNRNPL/PTBP1 to facilitate SETD7/LZTFL1 mRNA destabilization. Cancer Lett 520:121–131.
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu J, Yao Q, Wang Y, Liu Z, Zhang L. 2021. LncRNA SNHG6 promotes Wilms’ tumor progression through regulating miR-429/FRS2 axis. Cancer Biother Radiopharm. doi:10.1089/cbr.2020.3705
   Web of Science ®Google Scholar
• Wei J, Gao Y, Li Z, Jia H, Han B. 2021. LncRNA SNHG6 facilitates cell proliferation, migration, invasion and EMT by upregulating UCK2 and activating the Wnt/beta-catenin signaling in cervical cancer. Bioorg Chem. 120:105488.
   PubMedGoogle Scholar
• Xu H, He Y, Ma J, Zhao Y, Liu Y, Sun L, Su J. 2020. Inhibition of pyruvate dehydrogenase kinase1 by dicoumarol enhances the sensitivity of hepatocellular carcinoma cells to oxaliplatin via metabolic reprogramming. Int J Oncol. 57:733–742.
   PubMed Web of Science ®Google Scholar
• Xu M, Chen X, Lin K, Zeng K, Liu X, Xu X, Pan B, Xu T, Sun L, He B, et al. 2019. lncRNA SNHG6 regulates EZH2 expression by sponging miR-26a/b and miR-214 in colorectal cancer. J Hematol Oncol. 12:3.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Luo M, Cui X, O’Connell D, Yang Y. 2022. Long noncoding RNA NEAT1 promotes ferroptosis by modulating the miR-362-3p/MIOX axis as a ceRNA. Cell Death Differ. 29(9):1850–1863.
   PubMed Web of Science ®Google Scholar
• Zhao P, Deng Y, Wu Y, Guo Q, Zhou L, Yang X, Wang C. 2021. Long noncoding RNA SNHG6 promotes carcinogenesis by enhancing YBX1-mediated translation of HIF1alpha in clear cell renal cell carcinoma. FASEB J 35:e21160.
   PubMed Web of Science ®Google Scholar
• Zheng X, Gou Y, Jiang Z, Yang A, Yang Z, Qin S. 2021. Icaritin-induced FAM99A affects GLUT1-mediated glycolysis via regulating the JAK2/STAT3 pathway in hepatocellular carcinoma. Front Oncol. 11:740557.
   PubMed Web of Science ®Google Scholar